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Abstract
Although non-communicable diseases (NCDs) are the leading cause of morbidity and mortality world-
wide, the global policy response has not been commensurate with their health, economic and social
burden. This study examined factors facilitating and hampering the prioritization of NCDs on the
United Nations (UN) health agenda. Shiffman and Smith’s (Generation of political priority for global
health initiatives: a framework and case study of maternal mortality. The Lancet 370: 1370–9.) political
priority framework served as a structure for analysis of a review of NCD policy documents identified
through the World Health Organization’s (WHO) NCD Global Action Plan 2013–20, and complemented
by 11 semi-structured interviews with key informants from different sectors. The results show that a co-
hesive policy community exists, and leaders are present, however, actor power does not extend be-
yond the health sector and the role of guiding institutions and civil society have only recently gained
momentum. The framing of NCDs as four risk factors and four diseases does not necessarily resonate
with experts from the larger policy community, but the economic argument seems to have enabled
some traction to be gained. While many policy windows have occurred, their impact has been limited
by the institutional constraints of the WHO. Credible indicators and effective interventions exist, but
their applicability globally, especially in low- and middle-income countries, is questionable. To be ef-
fective, the NCD movement needs to expand beyond global health experts, foster civil society and de-
velop a broader and more inclusive global governance structure. Applying the Shiffman and Smith
framework for NCDs enabled different elements of how NCDs were able to get on the UN policy
agenda to be disentangled. Much work has been done to frame the challenges and solutions, but im-
plementation processes and their applicability remain challenging globally. NCD responses need to be
adapted to local contexts, focus sufficiently on both prevention and management of disease, and have
a stronger global governance structure.
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Introduction
Non-communicable diseases (NCDs) have featured on the World
Health Organization (WHO) agenda since the early 1980s (World
Health Organization, 1981) and have been on the rise globally
(Naghavi et al., 2017). Until September 2018, WHO included four
main diseases encompassed by the NCD category, namely cardio-
vascular diseases (CVD), chronic respiratory diseases (CRD), dia-
betes and cancers with mental health being added at this time. In
2016, NCDs accounted for 41 million deaths or 71% of global mor-
tality (World Health Organization, 2018a). CVD represented 31%,
cancers 16%, CRD 7%, diabetes 3% and other NCDs 15% of glo-
bal deaths. Low- and middle-income countries (LMIC) accounted
for 78% of all NCD deaths and 85% of premature adult NCD
deaths worldwide, with the risk of dying from an NCD being double
that for an adult in a high-income country (Naghavi et al., 2017).
Despite being the leading cause of morbidity and mortality world-
wide, NCDs have not received the same political or financial attention
from the global health community as other conditions, such as HIV/
AIDS (Beaglehole et al., 2011b; Horton, 2015; Dieleman et al., 2016)
with this group of diseases only receiving 1.7% of the US$37.6 billion
in development assistance for health (Dieleman et al., 2016). NCDs
were absent from the Millennium Development Goals (MDGs)
(Mamudu et al., 2011), but are now included in the Sustainable
Development Goals (SDG) (United Nations, 2016) with the WHO
having developed the Global Action Plan for the prevention and con-
trol of NCDs 2013–20 (GAP) (World Health Organization, 2013) as
a result of a United Nations High-Level Meeting (UNHLM) held in
2011 (UNGA, 2012). Both the SDGs and the GAP provide specific
goals and targets, among others the reduction of premature mortality
from NCDs by one-third by the year 2030. Both national and global
responses are needed, including political will and funding (Horton
and Sargent, 2018; Nugent et al., 2018).
The process of prioritizing health issues at global level is complex
and deeply political. A number of analytical frameworks can be used to
identify factors that shape political prioritization and policy-responses
(Walt et al., 2008; Gilson et al., 2018). It has long been recognized that
health policies are formed through complex inter-relationships of con-
tent, context, process and actors (Buse et al., 2012). This model first
proposed by Walt and Gilson (1994) to systematically evaluate differ-
ent factors that impact policy, was built on by Shiffman and Smith
(2007) with the introduction of further concepts using four categories
(1) the power of actors involved, (2) the ideas they use to portray the
issue, (3) the nature of the political contexts in which they operate and
(4) characteristics of the issue itself. (Table 1) This model has shown
relevance across many areas of health such as addressing alcohol harm
(Schmitz, 2016), maternal mortality (Shiffman and Smith, 2007), pneu-
monia (Berlan, 2016), surgically treatable conditions (Shawar et al.,
2015), tobacco use (Gneiting, 2016), urban health and tuberculosis
(Quissell and Walt, 2016; Shawar and Crane, 2017), but has not been
used to analyse how NCDs were included in the global health policy at
the UNHLM and WHO.
This study aims to understand how NCDs gained traction on the
global health agenda, which resulted in their inclusion in the 2011
UNHLM and the development of the GAP by WHO, using the
Shiffman and Smith (2007) framework to identify the factors facili-
tating or hampering this prioritization.
Methods
A similar approach to other researchers using the Shiffman and
Smith (2007) model was adopted combining document reviews and
key informant interviews using a case study method (Shiffman and
Smith, 2007; Shawar et al., 2015; Berlan, 2016; Gneiting, 2016;
Quissell and Walt, 2016; Schmitz, 2016; Shawar and Crane, 2017)
with a retrospective approach (Parsons, 1995). The methods are
detailed in Figure 1. As the aim was to identify factors leading to the
inclusion of NCDs in the 2011 UNHLM, with the WHO GAP
(World Health Organization, 2013) being used as a starting point
for the review of the literature as this was seen as the result of the
overall process of prioritization of NCDs. References included in the
GAP, NCD-related World Health Assembly (WHA) resolutions and
documents mentioned by interviewees were analysed using the
Shiffman and Smith framework. These documents and resolutions
provided information to develop a timeline displaying the trajectory
of key dates in the NCDs policy agenda, which was referenced dur-
ing in-depth interviews and drawn upon for the analysis of the dif-
ferent components of the Shiffman and Smith (2007) framework.
The policy analysis was complemented with key informant inter-
views. Based on the document review, a list of key actors and poten-
tial interviewees was developed. Three key informants (two from
the Civil Society, one from WHO/Government) were purposively
contacted due to their important roles in setting the NCD agenda
within the UN system. Further interviewees were identified through
snowball sampling. The interviews followed a discussion guide with
four sets of grand tour questions (Spradley, 1979) included in
Figure 1. Interviews were conducted in person or by phone between
February and September 2017 and lasted an average of 1 h. Each
interview was audio-recorded. All interviews were transcribed ver-
batim and anonymized. Verbatim transcriptions were iteratively
coded and clustered together with the document review using the
Shiffman and Smith (2007) framework meta-themes, for final ana-
lysis and interpretation. This study was approved by the
Commission Cantonale d’e´thique de la recherche Gene`ve in 2016.
Results
The document review identified 48 key documents, among which 19
WHO reports, 6 academic publications and reports, 1 regional
Key Messages
• Grouping of non-communicable diseases (NCDs) into one disease category improved traction in their prioritization.
• The economic framing, presenting rising costs and burden, was key to advance the issue on the global health policy
agenda.
• The network of NCD experts remains in the health realm and has not successfully expanded their political coalition to
other stakeholders whose engagement is required.
• There is the need for different policy approaches for NCD prevention vs NCD management and care.
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declaration (CARICOM), 17 WHA resolutions and 5 UN resolu-
tions, published between 1981 and 2017. (Table 2) The timeline
was complemented with findings from the interviews (Figure 2).
Eleven semi-structured interviews (female¼5/male¼6) were con-
ducted with individuals representing different sectors (WHO, civil
society, private sector, academia and government). It is interesting
to note that during the development process to reach the 2011
UNHLM and GAP, several of these individuals worked in different
sectors as described in Table 3. Findings from both the document re-
view and interviews are presented thematically, according to the
Shiffman and Smith (2007) model with quotes from interviews and
documents used to illustrate these themes.
Actor power
Actor Power is comprised of the strength of the individuals and
organizations concerned with the issue relating to policy community
cohesion, leadership, guiding institutions and civil society mobiliza-
tion. Key actors were identified as major influencers in the NCD
policy community, including individual champions and civil society,
regional political voting blocs, leading institutions and academia.
Policy community cohesion is defined as the degree of unity be-
tween the various actors involved in the issue (Shiffman and Smith,
2007). While there may still be a lack of policy community cohesion,
the geopolitical alignment of certain UN voting blocs was critical in
gaining the necessary traction to move towards a UNHLM and pol-
itical declaration for NCDs. Many of the interviewees described
mini-coalitions of countries or other stakeholders that joined forces
to get NCDs on the agenda.
[. . .] the Scandinavian governments, Sweden, Denmark, Norway
[. . .] have always been very strong on NCDs. . . . Then you’ve
also obviously got the [. . .] BRICS (Brazil, Russia, India, China,
South Africa) countries where the burden is the greatest, in terms
of sheer numbers. . . . BRICS countries [are] beginning to take
leadership role (I1).
Interviewees from NGOs, private sector, academia and WHO all
highlighted the leading role played by the Caribbean Community
(CARICOM) and also Commonwealth countries:
All the Caribbean countries got together. They all got together in
2007 (I2).
The Commonwealth countries had two political blocks:
There’s the Caribbean and there are the Pacific Islands. Both
those blocks, which when you put them all together, there you
have considerable voting numbers in the UN (I9).
Another cohesive group of actors was the NCD Alliance, created in
2009 by four disease-specific federations: International Diabetes
Federation (IDF), World Heart Federation, Union for International
Cancer Control and International Union Against Tuberculosis and
Lung Disease.
The reason why those four actors came together at that time was
because they all recognized that they had [. . .] gone as far as they
could in terms of their own advocacy on disease specific issues,
[. . .] They also recognized [. . .] a shared agenda around [. . .] the
shared risk factors and similar kind of health system response
required (I1).
Within the NCD policy community, various leaders advocating for
NCDs and policy development were mentioned by the informants.
Specifically, the leadership of the IDF was seen as:
a major proponent, a major supporter of there being a UN-type
meeting and the [CEO of IDF] also persuaded colleagues and the
other three organizations [. . .] that they should come together in
an alliance and that alliance was then a major proposer for there
to be international attention to NCDs (I3).
Table 1 The four categories of the Shiffman and Smith model
Element from model Description
Actor power
1. Policy community cohesion
2. Leadership
3. Guiding institutions
4. Civil society mobilization
Actor power is defined as, ‘the strength of the individuals and organizations concerned with the issue’. There
are four factors, namely policy community cohesion; leadership; guiding institutions; and civil society
mobilization.
1. The unity between the various actors involved in the issue is described
2. Identified champions for the cause capable of uniting the policy community.
3. Guiding institutions have the mandate to lead the initiative
4. The extent to which international and national political authorities are pressed from grassroots organ-
ization to tackle the issue at the global level.
Ideas
5. Internal frame
6. External frame
The way that the issue is portrayed and understood by those involved.
5. The internal frame seeks to grasp the level of agreement within the policy community of causes and
solutions.
6. The external frame looks at how this internal frame is endorsed or not by political leaders through
action.
Political contexts
7. Policy windows
8. Global governance structure
Political contexts are the overall environment in which the actors operate. It is composed of two elements.
7. Policy windows are given moments in time when actors can influence decision-makers as the policy en-
vironment is prepared to address this issue. These are, e.g. following a given political event, major disas-
ter, etc.
8. The global governance structure is the existence of a ‘platform’ to allow for ‘effective collective action’
to enforce a set of norms.
Issue characteristics
9. Credible indicators
10. Severity
11. Effective interventions
This component describes the different elements of the issue’s nature.
9. Looking at factors as whether or not there are clear measures that show the severity of the problem and
that also define how improvements are measured;
10. The magnitude of the issue vs other problems;
11. Whether or not cost-effective, evidence based, easy to achieve and low-cost measures exist and if these
can be easily understood by policymakers and implemented.
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Idenﬁcaon of other documents included as references in the
Analysis of GAP
 GAP as well as WHAs on NCDs
Review of documents
Development of list of potenal 
interviewees (29 people)Development of meline
Interviews using discussion guide with 4 Grand Tour quesons
(key dates in NCD policy agenda; key actors; key drivers and key challenges) 
and meline
Themac coding of documents using Shiﬀman and Smith framework
Idenﬁcaon of 2 further interviewees in addion to inial  list 
Verbam transcripon and coding
Combining of data from document review and interviews
Development discussion 
guide
3 inial interviews
6 interviews
Idenﬁcaon of 4 further interviewees 
in addion to inial list
2 addional interviews (total: 11)24 people not interviewed: refusal, unable to contact, etc.
Figure 1. Methodological approach.
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Specific individuals from the Caribbean were mentioned by all inter-
viewees as being:
Always the kind of political champions of the NCD issues, par-
ticularly [at] the UN (I1).
Academics were also seen as responsible for disseminating evidence
on the NCD burden. This included four series of publications from
the Lancet action group on NCDs (The Lancet, 2005, 2007, 2010,
2013). The role of the private sector was also highlighted by some of
the interviewees and in the GAP’s overarching principles and
approaches.
It should be recognized that effective NCD prevention and con-
trol require leadership, coordinated multi stakeholder engage-
ment for health both at government level and at the level of a
wide range of actors,. . . with relevant civil society and private
sector entities (World Health Organization, 2013).
In terms of guiding institutions, interviewees suggested that, the
technical lead was assumed by WHO, but that resulted in certain
limitations. As stated by I5, ‘[WHO] is not really the global police.
We are actually the Secretariat of the Member States’.
In order to expand the network of stakeholders involved and ad-
dress some of its institutional constraints, including the involvement
Table 2 Key documents reviewed 1979–2017
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of non-state actors and especially the private sector, WHO estab-
lished the Global Coordinating Mechanism (GCM) in 2014 (World
Health Organization, 2017a) with the aim to ensure the implemen-
tation of the GAP by engaging WHO Member States, UN organiza-
tions and non-state actors. The premise of the GCM was cited in the
GAP, as a ‘global mechanism to coordinate the activities of the UN
system and promote engagement, international cooperation, collab-
oration and accountability among all stakeholders’ (World Health
Organization, 2013). Some interviewees highlighted the limitation
of the GAP:
I don’t think what we’ve got at the global level is necessarily the right
kind of architecture to be moving forward. I don’t necessarily think
WHO is the one that will be able to do it. It’s just a question of how
you facilitate a shift outside of WHO on these issues (I1).
Much of the successful advocacy work to elevate the priority of
NCDs interventions parallels the emergence of the NCD Alliance.
However, civil society movements behind the four main diseases re-
main relatively fragmented and weak; as stated by I5:
Unlike HIV or TB, a collective civil society presence has not
come in NCDs.
I7 adds, a ‘lack of social mobilization is [a hurdle], definitely’.
Ideas
The Ideas category refers to the way that the issue is portrayed and
understood by those involved (Shiffman and Smith, 2007). It is com-
prised of the internal frame, which seeks to grasp the level of consen-
sus within the policy community, and the external frame which is
the public portrayal of the issue. Identifying a set of ideas to attract
political and public support has been a persistent challenge of NCDs
prioritization. This has resulted in an evolving framing used to char-
acterize NCDs, from focusing on morbidity and mortality to
Table 5. NCDs severity presented in WHO documents reviewed
WHO document Presentation of severity
Global Strategy for the Prevention and Control of NCDs, 2000 (World
Health Organization, 2000a)
NCDs were responsible for 60% in 1998 (or 31.7 million) deaths annually,
and represented 43% of the global burden of disease
Preventing chronic diseases: a vital investment, 2005 (World Health
Organization, 2005)
Chronic disease will account for 35 million deaths in 2005, which is double
the number of deaths from all infectious diseases (including HIV/AIDS, tu-
berculosis and malaria), maternal and perinatal conditions and nutritional
deficiencies combined
2008–13 Action Plan for global strategy for the prevention and control
of NCDs, 2008 (World Health Organization, 2008)
NCDs are growing to dominate healthcare needs in LMICs and that by 2013
these countries were already bearing 86% of the burden of NCD-related
deaths
Global status report on NCDs 2010, 2011 (World Health
Organization, 2011)
Need to launch a more forceful response to the growing threat posed by
NCDs.Particular attention is given to conditions in LMICs, which now bear
nearly 80% of the burden from NCDs.
From Burden to ‘Best Buys’: Reducing the Economic Impact of Non-
communicable diseases in LMICs, 2011 (World Economic Forum
and Harvard School of Public Health, 2011)
Cumulative economic losses to LMICs from the four core NCDs will exceed
USD 7 trillion between 2011 and 2025
The Global Economic Burden of NCDs, 2011 (Bloom et al., 2011) Over the following 20 years, NCDs would cost more than US$ 30 trillion,
which represented 48% of global GDP in 2010, and would push millions of
people below the poverty line
Global action plan for prevention and control of NCDs 2013–20,
2013 (World Health Organization, 2013)
63% of global deaths
Table 4 Global Action Plan voluntary targets for NCDs
1. A 25% relative reduction in risk of premature mortality from CVD, cancer, diabetes or CRD.
2. At least 10% relative reduction in the harmful use of alcohol, as appropriate, within the national context.
3. A 10% relative reduction in prevalence of insufficient physical activity
4. A 30% relative reduction in mean population intake of salt/sodium.
5. A 30% relative reduction in prevalence of current tobacco use in persons aged 15þ years.
6. A 25% relative reduction in the prevalence of raised blood pressure or contains the prevalence of raised blood pressure, according to national
circumstances.
7. Halt the rise of diabetes and obesity.
8. At least 50% of eligible people receive drug therapy and counselling (including glycaemic control) to prevent heart attacks and strokes.
9. An 80% availability of the affordable basic technologies and essential medicines, including generics, required to treat major NCDs in both public
and private facilities.
Table 3 Description of Interviewees by sector
WHO Civil society Private sector Academia Government
I1 X
I2 X
I3 X X X
I4 X
I5 X
I6 X
I7 X
I8 X X
I9 X
I10 X
I11 X x x
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economic and development concerns, and finally to the adoption of
a human rights approach.
The NCD policy community agreed in 2000 on the first framing
of NCDs as ‘4  4’, four risk factors and four diseases.
Four of the most prominent noncommunicable diseases—cardio-
vascular disease, cancer, chronic obstructive pulmonary
disease and diabetes—are linked by common preventable risk
factors related to lifestyle. These factors are tobacco use, un-
healthy diet and physical inactivity (World Health Organization,
2000a).
Several interviewees emphasized that this framing was needed to
simplify the complexity of NCDs as a group of diseases but also
stated:
The 4  4 isn’t perfect, but it’s what we’ve got (I9).
‘Best Buys’ for NCDs were developed as the solutions within the in-
ternal frame for the purpose of the external frame. This concept
appeared in WHO Global Status Report 2010, as ‘cost-effective,
feasible and affordable interventions in any resource setting’ (World
Health Organization, 2011). In the lead up to the 2011 UNHLM,
‘Best Buys’ were included in several key documents, most important-
ly the 2011 World Economic Forum (WEF) reports and WHO re-
port on scaling up action against NCDs (Bloom et al., 2011;
Chisholm et al., 2011; World Economic Forum and Harvard School
of Public Health, 2011). Subsequently, these were included in the
updated Appendix 3 of the GAP during 2017 World Health
Assembly (World Health Organization, 2017b).
The external framing of NCDs has used various ways of high-
lighting the importance of these diseases with security related, eco-
nomic development, sustainable development, socio-economic
development and finally human rights language used. Certain WHO
policies and strategies have employed the urgency of security-related
language. Framing NCDs as a threat to economic and human devel-
opment was first used in WHA51.18 (World Health Organization,
1998):
they [NCDs] cause enormous human suffering and threaten the
economies of Member States, where costly treatment will further
deprive the poor and powerless and increase the inequities in
health between population groups and countries (World Health
Organization, 1998).
The 2000 Global Strategy described the ‘global threat’ posed by
NCDs and the need to provide ‘urgent and effective public health
responses’ (World Health Organization, 2000a). In 2005, WHO
described NCDs as, ‘[. . .] an under-appreciated cause of poverty
and hinders the economic development of many countries’
(World Health Organization, 2005). In 2007, WHA60.23 noted
the ‘links between NCDs, development, the environment and
human security,’ as well as their contribution to ‘health inequal-
ities’ (World Health Organization, 2007). In 2008, the first action
plan towards a global strategy for prevention and control of
NCDs emphasized that addressing NCDs is ‘an integral part of
sustainable socioeconomic development’ (World Health
Organization, 2008). The 2011 UN Political Declaration focused
on the social, economic and development impact of NCDs on
countries, especially LMICs (UNGA, 2012). Currently, GAP high-
lights the work of WHO to ensure that the burden of NCDs
does not ‘undermine the development gains of past years’, (World
Health Organization, 2013). I1 provides an example of the differ-
ent portrayal of NCDs:
Everyone always throws around the figure of $47 trillion it’s
going to cost the world in the next two decades on NCDs. The
economic case became a lot clearer, as did the kind of rights and
social justice issues of NCDs. [. . .]. I think that is a kind of re-
framing of the issues, which I think helps catalyze physical
commitment.
Three challenges with regards to the external frame and the pro-
posed solutions for NCDs were detailed by the informants. Firstly,
the issue of prevention vs care:
What I have tried to set up here is a framework that makes it pos-
sible for politicians to make policy options on especially the pre-
vention side. The management side is only a kind of a conse-
quence of not being able to prevent properly (I7).
Secondly, the wider links between NCDs, development and human
rights:
A huge amount of push-back from a lot of the development com-
munity on NCDs being recognized as a development issue, des-
pite the fact that [NCDs are now] in the SDGs (I1).
Similarly, human rights language has difficulty emerging in the
framing:
[There is] still push-back in terms of recognizing that it’s a pov-
erty issue and a rights issue. They still claim that there’s not
enough evidence to prove that when there is (I1).
I7 adds, ‘you could ask the same question on human rights. The
only place in the global action plan where this is stated is in the over-
arching principles, and there is no operationalization of that’
Finally, how to provide policymakers with concrete solutions is
difficult for NCDs, despite the existence of the ‘Best Buys’ as:
We’ve never said that the 4  4 is transferable to every single
country and every single community. It’s obviously a bit like
IKEA furniture. You know people need to tailor it and fiddle
around until they get, that it makes sense to them in context (I1).
Political contexts
Political contexts are the overall environment in which the policy
actors operate (Shiffman and Smith, 2007). Two elements character-
ize this category; policy windows and global governance structures.
Policy windows provide actors with opportunities to influence deci-
sion-makers. While the global governance structure is the existence
of a ‘platform’ allowing for ‘effective collective action’ (Shiffman
and Smith, 2007). Although many policy windows for NCDs have
occurred, the limitations in the global governance structure meant
these windows did not yield the desired results. NCD policy win-
dows have mainly been global events bringing together a variety of
policymakers.
One policy window was a meeting in 2007 held by the
CARICOM countries that was instrumental in that it called for a
Resolution for a UNHLM and UN General Assembly support. The
outcome document, The Port of Spain Declaration marked the first
high-level political commitment to address NCDs, which was per-
ceived to be ‘a watershed moment’ (I2).
Another key policy window was the UNHLM in 2011. The grav-
ity of the situation had been grasped and ‘all the stars were in align-
ment’ (I3); particularly since the Port of Spain Declaration and the
creation of the NCD Alliance in 2009. While the political declaration
that came out of this meeting was not binding under international
law, it had political weight and was significant in the lead up to the
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SDGs. In this context, the successful inclusion of NCDs within the
SDGs (World Health Organization, 2017c) was seen as:
. . . Even bigger [than the UNHLM], because then it’s clearly
stated that NCD is not only a health threat but also a develop-
ment threat (I10).
In terms of global governance, WHO prioritized NCDs as one of six
clusters at the headquarters in 2018 (World Health Organization,
2018b). However, policies, strategies and resolutions continue to re-
flect the non-unified nature of different units or disease issues. For
example, a number of WHA Resolutions and WHO documents are
either specific to a given disease or risk factor (e.g. the Global
Strategy on Diet, Physical Activity and Health or the Global
Strategy to reduce the harmful use of alcohol) (World Health
Organization, 2004, 2010) or propose a more general approach
encompassing all NCDs and their risk factors (e.g. WHA53.17 and
WHA60.23 and the two NCD global action plans) (World Health
Organization, 2000b, 2007, 2008, 2013).
Interviewees noted that the GAP developed by WHO (World
Health Organization, 2013) was the response to the commitments
made by Heads of State and Governments in the UN Political
Declaration (UNGA, 2012). This was seen as the main guiding
document for the global NCD response. This document is used with-
in the global governance structure of WHO which operates only in
the area of health, and this was seen as needing to be expanded:
We can only plead and advocate that the Ministry of Transport
will reduce emissions, or the Ministry of Food to reduce sugar
[. . .] Ministries [of Health] are very weak. So, it all depends on
how the heads of the governments take it up. . . (I5).
Finally, I11 adds that:
There is no whole-of-society-approach. . . . you need a more
enlightened approach at WHO and amongst policymakers to get
out of a narrow, a few policies alone will do it, into a broader,
more creative mindset.
To address the challenge of WHO’s limitations in working beyond
the health sector, mechanisms were developed, such as GCM and
the United Nations Interagency Task Force on the Prevention and
Control of NCDs (UNIATF).
[GCM] Terribly named thing . . . I don’t think we’ve really
cracked the nut, in terms of what works, in terms of multi-
sectoral engagement. In terms of kind of the key players (I1).
I1 adds:
What we’re finding is that because [the GCM is] based in WHO
it’s fairly limited in terms of actually its ability to meaningfully
engage with civil society and private sector (I1).
One interviewee also recognized the positive development of
UNIATF in having more actors around the table discussing NCDs.
WHO is obviously the main technical agency, but now we’ve got
a UN inter-agency taskforce on NCDs which brings together all
sorts of different UN agencies around NCDs, which is an inter-
esting development from our perspective because now you’ve got
the World Bank, you’ve got UNICEF, you’ve got UNFPA,
UNAIDS, all beginning to talk about NCDs (I1).
Issue characteristics
Issue characteristics are comprised of credible indicators, severity
and effective interventions.
The GAP includes nine voluntary global targets, which aim to
measure changes, mortality, risk factors and use and access to medi-
cines (World Health Organization, 2013) (Table 4). Although iden-
tified as useful targets and objectives, informants question their
applicability globally:
[They] help mobilize and galvanize countries. As with any global
plan getting [. . .] to translate into national action; is not easy
(I2).
I1 adds about these targets:
It’s completely unrealistic and unfeasible to think that a low-income
country is going to be able to do everything [. . .] even setting itself
all nine targets and 25 indicators, which is exactly the same as the
global framework. It’s just not possible (I1).
In terms of severity, there is widespread consensus that NCDs
present an unprecedented and incomparable challenge to global and
national health systems (Beaglehole et al., 2011a). WHA resolutions
in 1985 and 1989 already alert to the strong impact of NCDs
(World Health Organization, 1985, 1989a, 1989b).
Recognizing that diabetes mellitus is a chronic, debilitating and
costly disease attended by severe complications including blind-
ness and heart and kidney disease; Noting that diabetes already
represents a significant burden on the public health services of
Member States, and that the problem is growing, especially in
developing countries (World Health Organization, 1989b).
I8 stated that,
There’s plenty of data out there. Not in the form that was avail-
able for consumption by policymakers and their advisors. It’s
very interesting a lot of our messaging at WHO was still in very
technical terms (I8).
The different ways of presenting the severity of NCDs in WHO
documents is included in Table 5.
Informants also cited the essential role of academic publications
in supporting the severity case of the issue in terms of ‘high mortal-
ity, morbidity, or socioeconomic cost’. I8 and I3 both discussed a
variety of publications in academic literature that provide substan-
tive evidence of the scale of the NCD challenge ahead:
Th[e] [Lancet Series 2005] was sort of making the academic case
(I8) and pointing out to the gravity of the problem and the need
for there to be a concerted, international attention (I3).
Both 2010 and 2014 global status reports on NCDs highlighted
the availability of effective interventions with evidence of clear and
measurable impact exemplified by specific case studies (World
Health Organization, 2011, 2014). Policy documents such as the
World Economic Forum (WEF)-WHO joint paper on ‘Best Buys’
focused on demonstrating the cost-effectiveness of policy response
options, which have proven to be effective in different contexts
(World Economic Forum and Harvard School of Public Health,
2011). However, the research shows that while tools are available,
implementation remains an issue:
Most of the interventions in low-income countries, and some in
high-income countries are not working, whether it is a regular
cancer screening or hypertension control or management of dia-
betes (I5).
The interventions described in the GAP include a list of options that,
while not exhaustive, are intended to provide information and
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guidance on effectiveness and cost-effectiveness of interventions
based on current evidence. Additionally, it is stated that when select-
ing interventions, consideration should be given to national circum-
stances (World Health Organization, 2013). Interviewees also
highlight that interventions for NCDs are complex:
I always say ‘what is the equivalent of a condom in diabetes?’ It
is not there. HIV, we can go to you in assembly and have a con-
dom in our hand and say, ‘this is it, use this, make this available,
you control the disease’ (I5).
Added to this complexity is the time lag between action and out-
come. I1 describes this as:
You’re not going to see very much impact if you’re going to be
investing in things like childhood obesity and tobacco control a
little bit more, alcohol control, these things take a long time. It’s
to do with behavior change. It’s to do with changing the environ-
ments that people are living in to promote healthy options and
that there’s no kind of magic bullet so kind of incentivizing fund-
ing into prevention, I think, is inherently very difficult.
Given the underlying social, economic and political factors of NCD
risk factors, proposed interventions may not be perceived as politic-
ally appealing in all contexts. Interviewees clearly express this
limitation.
You have the commitments, you have the tools, you know how
to measure, you measure it, you know how to hold people ac-
countable and still there is so little happening (I7).
This is compounded by two factors mentioned by I7 and I10: the
need for multi-sectorial plans and the issue of lack of funding at
both global and national levels.
Even if we have had more and more countries coming up
with national plans they are not really multi-sectoral and they
are not financed and they are not budgeted, they are not priori-
tized (I7).
Linkages between the different elements
The overall linkages between the different elements from Shiffman
and Smith framework detailed above are presented in Table 6. This
shows how the linkages between the different elements of the
Shiffman framework can be seen as bi-directional, with for actor
power being influenced by ideas and ideas influenced by the actors.
No single factor is sufficient to explain the relative lack of priority
afforded to these NCDs as a category over the past few decades, nor
their more recent rise on the global agenda.
Even though the emergence of NCDs as a political category of
diseases can be identified as early as the mid-1980s, recent years
have witnessed more documents, meetings and attention for NCDs
(Figure 2) with certain individuals being key in driving the NCD pol-
icy agenda. The network behind NCDs is predominantly confined
within the health sector, with this leadership from health experts
shaping both the framing of the issue, as well as proposed solutions.
The grouping of NCDs and their associated risk factors (4 4 fram-
ing) had an impact on both the issue characteristics and actor power.
For issue characteristics, this combination of the four NCDs leveraged
the severity and collective impact. In actor power, this consolidated and
strengthened the policy community cohesion, by creating a larger pool
of leaders to champion NCDs, and enabled the institutional prioritiza-
tion of NCDs as a focus area of the WHO. In parallel, this strengthened
civil society engagement through the creation of the NCD Alliance.
NCD advocates have been successful in creating policy windows
such as the UNHLMs or the inclusion of NCDs in the SDGs.
However, political decisions resulting from these opportunities have
yet to materialize in substantive ways. This is in part due to limita-
tion of the proposed solutions not being adapted to different con-
texts given the current global governance structure and actors
involved. WHO being central to global governance structure in
moving the NCD agenda forward is limited in the extent to which it
can engage other actors beyond Ministries of Health on this issue.
The CARICOM countries and their leading role show the import-
ance of the associations between the elements of the Shiffman and
Smith framework. The CARICOM’s role was based on the following
factors: unified voice of a group of countries (guiding institutions); in-
volvement of certain individuals playing multiple roles at national and
regional levels (leadership); inclusion of experts from different sectors
in the discussions which helped reframe the issue away from one pure-
ly focused on health (ideas and severity); the Port of Spain meeting
(policy window) was effectively used to garner support from the
CARICOM governments; and the CARICOM countries within the
UN system carry many votes (global governance structure). All these
elements translated into the issue being raised at the UN by the
CARICOM countries with their representatives at 2011 UNHLM
pushing for this agenda (leadership and global governance structure).
Discussion
This study highlights how institutions and leaders from the actor
power component were able to leverage existing evidence and use this
for action by framing NCDs in a more comprehensive way. Two fram-
ings were essential for NCDs to gain traction on the UN health
agenda. Firstly, the simplification of this disease category through the
4  4 framing, and secondly, the shift away from presenting NCDs in
terms of morbidity and mortality towards focusing on an economic ar-
gument which highlighted the development challenges. Civil society
was also able to effectively use the political grouping of diseases and
economic argument to attract political attention.
Community cohesion through CARICOM, NCD Alliance and
certain key leaders was instrumental in getting the UNHLM in
2011. These actors recognized that in order to move the NCD re-
sponse forward, the issue had to be politicized beyond the scope of
WHO to the wider attention of the UN. The UN was then able to re-
inforce WHO’s mandate of institutional leadership on the global
NCDs agenda. The inclusion of NCDs within the SDGs is possibly
the largest opportunity for the issue to be included in global and na-
tional responses as well as linked to wider issues included in the
SDGs, e.g. poverty, food security, education, etc.
Despite this progress, several issues prevail. These include the
need to further expand the NCD political coalition from the realm
of health to other stakeholders whose engagement is required to
make progress. WHO’s role is to shape global and national policy-
making, and its circle of influence is most often limited to health
ministries (Magnusson, 2010). The proposed interventions not only
require a wider implication of non-health actors, but also touch
upon complex issues from prevention to treatment. The UNIATF
and GCM are an opportunity to address these wider issues, but have
yet to truly accomplish this. In terms of framing some have called
for NCDs to be reframed as a threat to global security (Saha and
Alleyne, 2018). This argument is based on the rationale that health
issues which transcend nation state boundaries and pose a threat in
terms of health security often receive rapid prioritization, global at-
tention and funds (Horton, 2017).
In addition, there has been a relative lack of social mobilization
around a comprehensive strategy against NCDs, and civil society
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actors often remained divided and failed to become true advocates
for NCDs (Horton, 2015). This may be in part due to the challenges
of the competing components of the NCD category, which is broad-
ly conceived with the notable absence of mental health within the 4
 4 category (Ngo et al., 2013). This was recently rectified during
the 2018 UNHLM (World Health Organization, 2018b) where
mental health and air pollution were added. Another possible reason
is that the network of civil society for NCDs is comprised of individ-
ual organizations dedicated to promoting progress against a specific
disease, or set of diseases, instead of ‘NCDs’ as a whole.
The methodology used in this study is similar to other studies
that have used the Shiffman and Smith framework as a mean to ana-
lyse different health issues (Shiffman and Smith, 2007; Shawar et al.,
2015; Berlan, 2016; Gneiting, 2016; Quissell and Walt, 2016;
Schmitz, 2016; Shawar and Crane, 2017). The use of this frame-
work strengthens the results by focusing on factors already shown to
be significant in other areas of global health prioritization (Shiffman
and Smith, 2007). The use of WHO GAP as a starting point is a limi-
tation as this puts a certain focus on documents developed by
WHO. A further limitation includes our access to and inclusion of
only publicly available documents. As with any qualitative study,
issues of bias exist, but the involvement of a multi-disciplinary team
aimed to mitigate this both at the time of the interviews and during
analysis of the data. Limitations include the date of the interviews
and document review; interviews were carried out in 2017 and the
document review does not include more recent documents related to
the UNHLM in 2018 and the recent report of WHO Independent
High-Level Commission on NCDs (World Health Organization,
2018c). However, given that this study covers key elements of the
NCD policy agenda as well as being the first time to our knowledge
that a comprehensive analysis of how this group of diseases gained
attention in the UN system, it provides a clear contribution to the lit-
erature. Our interviews were also with individuals actively involved
in the overall process of NCDs policymaking within WHO, thus
limiting the view on the issue. That said the central role of WHO as
well as small group of individuals in placing NCDs on the agenda is
a key finding from this article and as discussed, a limitation on why
the NCD agenda has not progressed. Using snowball sampling pos-
sibly biased the individuals included in this study, however, the
interviewees included are from a range of different sectors.
It is proposed that the NCD response would benefit from ‘splitting’
the issue in two, with on the one hand a focus on risk factors and on
the other access to treatment and care. The UNLM 2011 Declaration
and GAP (UNGA, 2012; World Health Organization, 2013) have
mostly focused on prevention while the absence of access to treatment
and care is notably absent from policy and responses, with only two
out of the eight targets in the GAP addressing this issue.
Risk factors for NCDs are multi-dimensional comprising bio-
logical, social, behavioural, economic and environmental factors.
This limits the impact that any single intervention can make. The
Framework Convention on Tobacco Control (FCTC) is a unique
global health response in that it was the only time WHO used its
role to negotiate an international treaty which resulted in binding
international commitments (Wipfli, 2016) and allowed a specific
governance mechanism to be developed for addressing one of the
main NCD risk factors (Gneiting, 2016). This could serve as a
model for other risk factors, even if these are more complex to deal
with, and that for tobacco there was a certain ‘exceptionalism’
(Collin, 2012) due to its undisputed harmful nature.
The inclusion of NCDs and Universal Health Coverage (UHC)
in the SDGs provides a unique opportunity for framing the issue of
access to NCD treatments within a development, poverty and
human rights perspective, as was the case for HIV/AIDS (Enoch
and Piot, 2017). For treatment-related aspects, different actors
need to be involved than for addressing the risk factors, evidence
needs to be differentiated with local action prioritized over global
co-ordination. Insofar as the pharmaceutical industry has shown
some positive contributions to improve access to medications in
other disease areas, engagement with the private sector will be ne-
cessary (Beran et al., 2017). In parallel wider issues of strengthen-
ing health systems focusing on Primary Health Care are needed
(Beran et al., 2016).
Nishtar, WHO Independent High-Level Commission Chair, re-
cently stated, ‘The good news on NCDs is that policymakers have
both an awareness of the problem and an appetite for change.
Unfortunately, this is not paralleled with action’ (Nishtar, 2017).
This comment is supported by WHO’s NCD progress monitor
showing that progress around the world has been uneven and insuf-
ficient, highlighting the need for bolder political action including the
mobilization of domestic and external resources and safeguarding
communities from interference by powerful economic operators
(e.g. Tobacco and sugar industry) (World Health Organization,
2017d). Although the third UNHLM on NCDs in 2018 could have
been seen as another policy window to further the global response
for NCDs, the political declaration was described as ‘vague and un-
ambitious’ (NCD Alliance, 2018). Recent changes in the structure at
WHO have relegated the importance of NCDs with the disappear-
ance of a specific Assistant Director General responsible for NCDs
(World Health Organization, 2019); however, the high-level com-
mission on NCDs (World Health Organization, 2019b) offers the
opportunity of new leadership on NCDs albeit with a mandate end-
ing this year. A real civil society movement and developing a global
governance structure similar to the FCTC is warranted for the pre-
vention-related agenda. With regards to access to care and medicines
the overarching UHC agenda, also part of the SDGs, and national
solutions need to be found, funded and implemented.
Conclusion
NCDs represent a formidable policy and governance challenge for
the global health community. The above analysis highlights three
key lessons. Detailing the wide-ranging impact of NCDs was
enabled through actors coming together and developing an evolving
frame for these conditions by not only focusing on health-related
factors, four diseases and risk factors, but also the economic and de-
velopment impact arguments. Secondly, the nature of NCDs and
associated risk factors are complex and inter-sectoral and require
leadership, civil society mobilization and a coalition beyond the
health sector. To date the proposed ‘Best Buys’ have limitations in
their applicability, both at global and national levels, as well as lack-
ing an effective mechanism for implementation and commitments.
The SDGs offer the NCD community an opportunity as they not
only include NCD specific targets, but also wide-ranging factors
relevant to addressing this health challenge. Overall, there is the
need for the NCD community to divide the issue into two compo-
nents, prevention and treatment and care, as these require a different
policy response at global and national level to ‘ensure healthy lives
and promote well-being for all at all ages’.
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